Northern Trust
FHTX icon

Northern Trust’s Foghorn Therapeutics FHTX Stock Holding History

Northern Trust’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Buy
309,775
+33,900
+12% +$150K ﹤0.01% 3293
2026
Q1 		$1.32M Buy
275,875
+13,445
+5% +$73.8K ﹤0.01% 3196
2025
Q4 		$1.42M Sell
262,430
-21,871
-8% -$99.2K ﹤0.01% 3187
2025
Q3 		$1.39M Sell
284,301
-2,399
-0.8% -$12.7K ﹤0.01% 3227
2025
Q2 		$1.35M Buy
286,700
+39,395
+16% +$165K ﹤0.01% 3224
2025
Q1 		$903K Sell
247,305
-6,366
-3% -$29K ﹤0.01% 3328
2024
Q4 		$1.2M Buy
253,671
+2,873
+1% +$20.9K ﹤0.01% 3309
2024
Q3 		$2.33M Buy
250,798
+59,847
+31% +$433K ﹤0.01% 2903
2024
Q2 		$1.1M Sell
190,951
-4,291
-2% -$25.6K ﹤0.01% 3202
2024
Q1 		$1.31M Sell
195,242
-4,032
-2% -$22.4K ﹤0.01% 3187
2023
Q4 		$1.29M Sell
199,274
-2,037
-1% -$8.79K ﹤0.01% 3221
2023
Q3 		$1.01M Sell
201,311
-854
-0.4% -$6.58K ﹤0.01% 3295
2023
Q2 		$1.42M Buy
202,165
+16,090
+9% +$113K ﹤0.01% 3209
2023
Q1 		$1.15M Buy
186,075
+4,662
+3% +$30.5K ﹤0.01% 3175
2022
Q4 		$1.16M Sell
181,413
-2,736
-1% -$20.6K ﹤0.01% 3206
2022
Q3 		$1.58M Sell
184,149
-2,849
-2% -$36.7K ﹤0.01% 3134
2022
Q2 		$2.54M Buy
186,998
+18,536
+11% +$239K ﹤0.01% 2921
2022
Q1 		$2.57M Sell
168,462
-2,014
-1% -$27.6K ﹤0.01% 2967
2021
Q4 		$3.9M Sell
170,476
-4,596
-3% -$66.1K ﹤0.01% 2843
2021
Q3 		$2.44M Buy
175,072
+12,172
+7% +$135K ﹤0.01% 3173
2021
Q2 		$1.74M Buy
162,900
+78,604
+93% +$857K ﹤0.01% 3395
2021
Q1 		$1.11M Sell
84,296
-4,142
-5% -$67.9K ﹤0.01% 3543
2020
Q4 		$1.79M Buy
+88,438
New +$1.69M ﹤0.01% 3243

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Northern Trust's FHTX Position: Q2 2026 in Review

Northern Trust increased its Foghorn Therapeutics (FHTX) stake by 12% in Q2 2026, buying an estimated $150K and bringing the position to 309,775 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #3293.

Northern Trust first reported a position in FHTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.9M in Q4 2021. 102 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Northern Trust held 309,775 shares of Foghorn Therapeutics worth $1.51M as of Q2 2026.
  • Northern Trust bought 33,900 Foghorn Therapeutics shares in Q2 2026, an estimated $150K.
  • Foghorn Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3293 holding.
  • Northern Trust first reported a position in Foghorn Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • Northern Trust's Foghorn Therapeutics position peaked at $3.9M in Q4 2021.
  • 102 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.